Lion Biotechnologies has appointed Gregory Schiffman as CFO. Schiffman brings fifteen years of experience holding leadership roles in financial operations and strategy in publicly-traded healthcare companies, such as Dendreon, Affymetrix, and Applied Biosystems. Most recently, he served as executive vice president and CFO of StemCells. Prior to StemCells, Schiffman served as executive vice president and CFO of Dendron. Before his work in the healthcare industry, he held roles of increasing responsibility at Hewlett Packard, including serving as controller of its European personal computer manufacturing and distribution operations in Grenoble, France, and as manufacturing and controller of its Netmetrix division.